Ramsay Santé
Fabrice Roy has over 25 years of work experience in various financial and leadership roles. Fabrice is currently the Chief Financial Officer (CFO) for Ramsay Santé in France. Before joining Ramsay Santé in 2022, Fabrice served as the CFO for Securitas France from 2017 to 2022. Prior to that, they worked at SUEZ, where they held several CFO positions in different areas of the company's Recycling & Recovery France division. Fabrice also has experience in the finance departments of Danone and Groupe Casino. Fabrice began their career as a Corporate Banking Analyst at BNP Paribas in Madrid. Overall, their work experience highlights their expertise in finance, accounting, and leadership roles within the healthcare, security, waste management, and consumer goods sectors.
Fabrice Roy attended emlyon business school from 1994 to 1998, where they obtained a DCG (formerly known as DECF) degree in accounting. Before that, from 1992 to 1994, they prepared for the Business School Entrance Exam at Lycée du Parc.
This person is not in any offices
Ramsay Santé
1 followers
After the acquisition of the Capio Group in 2018, Ramsay Santé has become Europe's leading private hospital and primary care companies. The group now has 36,000 employees and works with nearly 8,600 private practitioners. Present in 5 countries, France, Sweden, Norway, Denmark and Italy, the group treats more than 7 million patients per year in its 350 establishments. In hospitalization, Ramsay Santé offers almost all medical and surgical treatments in three business lines: Medicine-Surgery-Obstetrics (MCO), Follow-up and Rehabilitation Care (SSR) and Mental Health. Wherever it is present, the group participates in public health service missions and in the health network of the country, as in Sweden where the group has more than a hundred local health centres. The quality and safety of care is the group's priority in all the countries where it operates. This is why the group is today one of the references in modern medicine, especially in ambulatory surgery and enhanced recovery after surgery (ARS). The group also invests more than €200 million every year in its establishments, whether in new surgical and imaging technologies, or in the construction and modernisation of establishments. It also innovates at the service of patients with new digital tools and by developing its organisations to improve the efficiency of care.